Historical record - last NADAC publication: 9/19/2018
Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Cambridge Therapeutics Technologies, LLC, priced at $0.0299 per EA under NDC 70882012530. Its NADAC has been published 36 times since Nov 1, 2017.
Strength
850 mg/1
Manufacturer
Cambridge Therapeutics Technologies, LLCNDC
70882012530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
9/19/2018
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091184On Market Since
1/31/2011
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 36 times since Nov 1, 2017, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0299 per EA |
|---|---|
| All-time high | $0.0323 (Nov 15, 2017) |
| All-time low | $0.0287 (Jul 18, 2018) |
| Median price | $0.0293 |
| Average price | $0.0296 |
| Largest weekly change | -9.8% (May 30, 2018) |
| Weeks tracked | 36 |
| Tracking since | Nov 1, 2017 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Cambridge Therapeutics Technologies, LLC, is $0.0299 per EA (NDC 70882012530), effective Oct 3, 2018.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 7.5%. It has been tracked across 36 weekly CMS publications since Nov 1, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Nov 1, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0287 (Jul 18, 2018) to a high of $0.0323 (Nov 15, 2017), with a median of $0.0293 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0247 per EA — about 18% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 70882012530) is labeled by Cambridge Therapeutics Technologies, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification